Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Assessment of Agrimonia eupatoria L. and Lipophosphonoxin (DR-6180) Combination for Wound Repair: Bridging the Gap Between Phytomedicine and Organic Chemistry

M. Kaňuchová, V. Brindza Lachová, K. Bogdanová, J. Sabová, P. Bonová, T. Vasilenko, I. Kováč, M. Novotný, P. Mitrengová, N. Sahatsapan, M. Čoma, E. Švajdlenka, M. Kolář, P. Bohuš, P. Mučaji, R. Zajíček, D. Rejman, P. Gál

. 2024 ; 14 (12) : . [pub] 20241212

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25010569

Grantová podpora
VEGA-1/0455/22, VEGA-1/0226/22 and VEGA-1/0262/24 Ministry of Education, Science, Research and Sport of the Slovak Republic
APVV-20-0017 and APVV-22-0006 Slovak Research and Development Agency
NW24-08-00073 Agentura Pro Zdravotnický Výzkum České Republiky
22-08857S Czech Science Foundation
LX22NPO5103 European Union
09I03-03-V04-00075 European Union

Agrimonia eupatoria L. (AE) has a rich tradition of use in wound healing improvement across various cultures worldwide. In previous studies, we revealed that Agrimonia eupatoria L. water extract (AE) possesses a rich polyphenolic composition, displaying remarkable antioxidant properties. Our investigations also demonstrated that lipophosphonoxin (LPPO) exhibited antibacterial efficacy in vitro while preserving the proliferation and differentiation of fibroblasts and keratinocytes. Building upon our prior findings, in this study, we intended to examine whether a combination of AE and LPPO could enhance skin wound healing while retaining antibacterial attributes. The antibacterial activity of AE/LPPO against Staphylococcus aureus was evaluated, alongside its effects on fibroblast-to-myofibroblast transition, the formation of extracellular matrix (ECM), and endothelial cells and keratinocyte proliferation/phenotype. We also investigated AE/LPPO's impact on TGF-β1 and VEGF-A signaling in keratinocytes/fibroblasts and endothelial cells, respectively. Additionally, wound healing progression in rats was examined through macroscopic observation and histological analysis. Our results indicate that AE/LPPO promotes myofibroblast-like phenotypic changes and augments ECM deposition. Clinically relevant, the AE/LPPO did not disrupt TGF-β1 and VEGF-A signaling and accelerated wound closure in rats. Notably, while AE and LPPO individually exhibited antibacterial activity, their combination did not lead to synergism, rather decreasing antibacterial activity, warranting further examination. These findings underscore substantial wound healing improvement facilitated by AE/LPPO, requiring further exploration in animal models closer to human physiology.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25010569
003      
CZ-PrNML
005      
20250716144856.0
007      
ta
008      
250415s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/biom14121590 $2 doi
035    __
$a (PubMed)39766296
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kaňuchová, Miriam $u Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 04001 Košice, Slovakia $7 xx0334081
245    10
$a Assessment of Agrimonia eupatoria L. and Lipophosphonoxin (DR-6180) Combination for Wound Repair: Bridging the Gap Between Phytomedicine and Organic Chemistry / $c M. Kaňuchová, V. Brindza Lachová, K. Bogdanová, J. Sabová, P. Bonová, T. Vasilenko, I. Kováč, M. Novotný, P. Mitrengová, N. Sahatsapan, M. Čoma, E. Švajdlenka, M. Kolář, P. Bohuš, P. Mučaji, R. Zajíček, D. Rejman, P. Gál
520    9_
$a Agrimonia eupatoria L. (AE) has a rich tradition of use in wound healing improvement across various cultures worldwide. In previous studies, we revealed that Agrimonia eupatoria L. water extract (AE) possesses a rich polyphenolic composition, displaying remarkable antioxidant properties. Our investigations also demonstrated that lipophosphonoxin (LPPO) exhibited antibacterial efficacy in vitro while preserving the proliferation and differentiation of fibroblasts and keratinocytes. Building upon our prior findings, in this study, we intended to examine whether a combination of AE and LPPO could enhance skin wound healing while retaining antibacterial attributes. The antibacterial activity of AE/LPPO against Staphylococcus aureus was evaluated, alongside its effects on fibroblast-to-myofibroblast transition, the formation of extracellular matrix (ECM), and endothelial cells and keratinocyte proliferation/phenotype. We also investigated AE/LPPO's impact on TGF-β1 and VEGF-A signaling in keratinocytes/fibroblasts and endothelial cells, respectively. Additionally, wound healing progression in rats was examined through macroscopic observation and histological analysis. Our results indicate that AE/LPPO promotes myofibroblast-like phenotypic changes and augments ECM deposition. Clinically relevant, the AE/LPPO did not disrupt TGF-β1 and VEGF-A signaling and accelerated wound closure in rats. Notably, while AE and LPPO individually exhibited antibacterial activity, their combination did not lead to synergism, rather decreasing antibacterial activity, warranting further examination. These findings underscore substantial wound healing improvement facilitated by AE/LPPO, requiring further exploration in animal models closer to human physiology.
650    12
$a hojení ran $x účinky léků $7 D014945
650    _2
$a zvířata $7 D000818
650    _2
$a lidé $7 D006801
650    _2
$a krysa rodu Rattus $7 D051381
650    12
$a rostlinné extrakty $x farmakologie $x chemie $7 D010936
650    12
$a Staphylococcus aureus $x účinky léků $7 D013211
650    12
$a antibakteriální látky $x farmakologie $x chemie $7 D000900
650    12
$a Agrimonia $x chemie $7 D031981
650    _2
$a fibroblasty $x účinky léků $x metabolismus $7 D005347
650    _2
$a keratinocyty $x účinky léků $7 D015603
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a vaskulární endoteliální růstový faktor A $x metabolismus $7 D042461
650    _2
$a transformující růstový faktor beta1 $x metabolismus $7 D053773
650    _2
$a potkani Sprague-Dawley $7 D017207
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brindza Lachová, Veronika $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia
700    1_
$a Bogdanová, Kateřina $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University, 779 00 Olomouc, Czech Republic
700    1_
$a Sabová, Jana $u Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 04001 Košice, Slovakia $1 https://orcid.org/0009000628218150
700    1_
$a Bonová, Petra $u Institute of Neurobiology, Biomedical Research Center of the Slovak Academy of Sciences, 04001 Košice, Slovakia $1 https://orcid.org/0000000254278126
700    1_
$a Vasilenko, Tomáš $u Department of Surgery, AGEL Hospital Košice-Šaca, Pavol Jozef Šafárik University, 04001 Košice, Slovakia
700    1_
$a Kováč, Ivan $u Second Department of Surgery, Louis Pasteur University Hospital, Pavol Jozef Šafárik University, 040 11 Košice, Slovakia
700    1_
$a Novotný, Martin $u Department of Infectology and Travel Medicine, Louis Pasteur University Hospital, Pavol Jozef Šafárik University, 040 11 Košice, Slovakia
700    1_
$a Mitrengová, Petra $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia
700    1_
$a Sahatsapan, Nitjawan $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., 160 00 Prague, Czech Republic
700    1_
$a Čoma, Matúš $u Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 04001 Košice, Slovakia $u Department of Biomedical Research, East-Slovak Institute of Cardiovascular Diseases, 040 11 Košice, Slovakia
700    1_
$a Švajdlenka, Emil $u Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia $u Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, 601 77 Brno, Czech Republic
700    1_
$a Kolář, Milan $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University, 779 00 Olomouc, Czech Republic $1 https://orcid.org/0000000346218868 $7 jn20010310083
700    1_
$a Bohuš, Peter $u Department of Pathology, Louis Pasteur University Hospital, Pavol Jozef Šafárik University, 040 11 Košice, Slovakia
700    1_
$a Mučaji, Pavel $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia $1 https://orcid.org/0000000344902615 $7 xx0062389
700    1_
$a Zajíček, Robert $u Prague Burn Center, Third Faculty of Medicine, University Hospital Královske Vinohrady, Charles University, 100 00 Prague, Czech Republic $7 xx0098569
700    1_
$a Rejman, Dominik $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences v.v.i., 160 00 Prague, Czech Republic
700    1_
$a Gál, Peter $u Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University, 04001 Košice, Slovakia $u Department of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University, 832 32 Bratislava, Slovakia $u Department of Biomedical Research, East-Slovak Institute of Cardiovascular Diseases, 040 11 Košice, Slovakia $u Prague Burn Center, Third Faculty of Medicine, University Hospital Královske Vinohrady, Charles University, 100 00 Prague, Czech Republic $1 https://orcid.org/0000000233983408 $7 xx0320027 xx0126576
773    0_
$w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 14, č. 12 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39766296 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250716144839 $b ABA008
999    __
$a ok $b bmc $g 2311751 $s 1247650
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c 12 $e 20241212 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
GRA    __
$a VEGA-1/0455/22, VEGA-1/0226/22 and VEGA-1/0262/24 $p Ministry of Education, Science, Research and Sport of the Slovak Republic
GRA    __
$a APVV-20-0017 and APVV-22-0006 $p Slovak Research and Development Agency
GRA    __
$a NW24-08-00073 $p Agentura Pro Zdravotnický Výzkum České Republiky
GRA    __
$a 22-08857S $p Czech Science Foundation
GRA    __
$a LX22NPO5103 $p European Union
GRA    __
$a 09I03-03-V04-00075 $p European Union
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace